First Trust Advisors LP Cytokinetics Inc Transaction History

First Trust Advisors LP

$101 Billion
Q3 2024

A detailed history of First Trust Advisors LP transactions in Cytokinetics Inc stock. As of the latest transaction made, First Trust Advisors LP holds 12,039 shares of CYTK stock, worth $625,305. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,039

Previous 21,389 43.71%

Holding current value

$625,305

Previous $1.16 Million 45.16%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$51.22 - $60.16 $478,907 - $562,496	-9,350 Reduced 43.71%	12,039 $635,000
Q2 2024 Aug 13, 2024	SELL	$47.86 - $75.05 $792,561 - $1.24 Million	-16,560 Reduced 43.64%	21,389 $1.16 Million
Q1 2024 May 13, 2024	BUY	$63.75 - $108.06 $2.42 Million - $4.1 Million	37,949 New	37,949 $2.66 Million
Q1 2023 May 15, 2023	SELL	$33.36 - $45.71 $1.67 Million - $2.29 Million	-50,019 Reduced 46.18%	58,292 $2.05 Million
Q4 2022 Feb 09, 2023	BUY	$35.77 - $51.11 $1.5 Million - $2.14 Million	41,947 Added 63.21%	108,311 $4.96 Million
Q3 2022 Nov 14, 2022	BUY	$38.54 - $54.52 $1.21 Million - $1.72 Million	31,485 Added 90.27%	66,364 $3.22 Million
Q2 2022 Aug 12, 2022	SELL	$33.93 - $48.92 $1.09 Million - $1.57 Million	-32,123 Reduced 47.94%	34,879 $1.37 Million
Q1 2022 May 13, 2022	SELL	$29.74 - $46.0 $2.59 Million - $4.01 Million	-87,077 Reduced 56.51%	67,002 $2.47 Million
Q4 2021 Feb 08, 2022	BUY	$34.35 - $46.38 $5.29 Million - $7.15 Million	154,079 New	154,079 $7.02 Million
Q3 2021 Nov 15, 2021	SELL	$18.54 - $35.74 $1.41 Million - $2.71 Million	-75,858 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$19.79 - $26.99 $525,820 - $717,124	26,570 Added 53.91%	75,858 $1.5 Million
Q1 2021 May 14, 2021	BUY	$18.57 - $25.68 $196,526 - $271,771	10,583 Added 27.34%	49,288 $1.15 Million
Q4 2020 Feb 02, 2021	BUY	$15.26 - $28.61 $590,638 - $1.11 Million	38,705 New	38,705 $804,000

Others Institutions Holding CYTK

# of Institutions

410

Shares Held

125M

Call Options Held

4.6M

Put Options Held

2.43M

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.89B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Account

First Trust Advisors LP Cytokinetics Inc Transaction History